Search

Your search keyword '"Sanguin"' showing total 1,288 results

Search Constraints

Start Over You searched for: Author "Sanguin" Remove constraint Author: "Sanguin"
1,288 results on '"Sanguin"'

Search Results

1. Osteopontin is a therapeutic target that drives breast cancer recurrence

3. Agroecological crop protection for sustainable agriculture

6. Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency

11. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression

19. How deep can ectomycorrhizas go? A case study on Pisolithus down to 4 meters in a Brazilian eucalypt plantation

21. Supplementary Data Legends from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer

22. Supplementary Figures from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer

23. Data from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer

31. HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer

37. An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis

38. Marknadshyror : Vilka ekonomiska effekter kan fastighetsägare få av införande av marknadshyror?

39. Data from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

40. Supplemental Figure 2 In vitro role of FIP1C in regulating cell proliferation in ErbB2/neuNDL primary cells from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

41. Supplemental Figure 3 Characterization of FIP1C/ErbB2/neuNDL cell lines in regulating tumor growth using athymic NCr mice from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

42. Supplemental Materials and Methods from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

43. Supplemental Figure Legends from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

44. Supplemental Figure 1 Schematics of the tetracycline inducible-FIP1C-MTB and inducible knock-out FIP1C mouse models from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

45. Supplemental Figure 5 FIP1C is not distribute at adjacent junctional complexes. Clinical relevance of FIP1C in Her2-positive breast cancer patients from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

46. Supplemental Figure 4 FIP1C is a negative modulator of Akt and MAPK activation in an ErbB2-driven model from Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

49. Supplementary Figure 1 from β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression

Catalog

Books, media, physical & digital resources